Search Results - Justine Y. Bruce
- Showing 1 - 11 results of 11
-
1
-
2
A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing... by Justine Y. Bruce, Jens C. Eickhoff, Роберто Пили, Theodore F. Logan, Michael A. Carducci, Jamie Arnott, Anthony M. Treston, George Wilding, Glenn Liu
Published 2010Artigo -
3
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours by Devalingam Mahalingam, George Wilding, Samuel R. Denmeade, J. Sarantopoulas, David Cosgrove, Jeremy Cetnar, Nilofer S. Azad, Justine Y. Bruce, Michael R. Kurman, Victoria Allgood, Michael A. Carducci
Published 2016Artigo -
4
A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer by Emmanuel S. Antonarakis, Elisabeth I. Heath, Edwin M. Posadas, Evan Y. Yu, Michael R. Harrison, Justine Y. Bruce, Steve Y. Cho, Gregory E. Wilding, Gerald J. Fetterly, David Hangauer, Min-Fun R. Kwan, Lyn M. Dyster, Michael A. Carducci
Published 2013Artigo -
5
A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy by Rana R. McKay, Amado J. Zurita, Lillian Werner, Justine Y. Bruce, Michael A. Carducci, Mark N. Stein, Elisabeth I. Heath, Arif Hussain, Hai T. Tran, Christopher J. Sweeney, Robert W. Ross, Philip W. Kantoff, Susan F. Slovin, Mary-Ellen Taplin
Published 2016Artigo -
6
Stress Keratin 17 Expression in Head and Neck Cancer Contributes to Immune Evasion and Resistance to Immune-Checkpoint Blockade by Wei Wang, Taja Ložar, Athena E. Golfinos, Denis Lee, Ellery Gronski, Ella Ward-Shaw, Mitchell Hayes, Justine Y. Bruce, Randall J. Kimple, Rong Hu, Paul M. Harari, Jin Xu, Aysenur Keske, Paul M. Sondel, Megan B. Fitzpatrick, Huy Q. Dinh, Paul F. Lambert
Published 2022Artigo -
7
Bimodal liquid biopsy for cancer immunotherapy based on peptide engineering and nanoscale analysis by Jiyoon Bu, Woo‐Jin Jeong, Roya Jafari, Luke J. Kubiatowicz, Ashita Nair, Michael J. Poellmann, Rachel Hong, Elizabeth W. Liu, Randall H. Owen, Piper A. Rawding, Caroline M. Hopkins, DaWon Kim, Daniel J. George, Andrew J. Armstrong, Petr Král, Andrew Z. Wang, Justine Y. Bruce, Tian Zhang, Randall J. Kimple, Seungpyo Hong
Published 2022Artigo -
8
AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck Cancer by Nellie K. McDaniel, Mari Iida, Kwangok P. Nickel, Colin A. Longhurst, Samantha R. Fischbach, Tamara S. Rodems, Carlene A. Kranjac, Amber Y. Bo, Qianyun Luo, Meghan M. Gallagher, Noah B. Welke, Kaitlyn R. Mitchell, Alison E. Schulz, Jaimee C. Eckers, Rong Hu, Ravi Salgia, Seungpyo Hong, Justine Y. Bruce, Randall J. Kimple, Deric L. Wheeler
Published 2020Artigo -
9
Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in<i>PIK3CA</i>- and<i>HRAS</i>-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity by Alison Smith, Stacia Chan, Zhiyong Wang, Asako McCloskey, Quinn Reilly, Jayden Z. Wang, Hetika Vora Patel, Keiichi Koshizuka, Harris S. Soifer, Linda Kessler, Ashley Dayoub, Victoria Villaflor, Douglas R. Adkins, Justine Y. Bruce, Alan L. Ho, Cesar A. Perez, Glenn J. Hanna, Amaya Gascó Hernández, Andrew Saunders, Stephen Dale, J. Silvio Gutkind, Francis Burrows, Shivani Malik
Published 2023Artigo -
10
Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology by Robert A. Swarm, Judith A. Paice, Doralina L. Anghelescu, Madhuri Are, Justine Y. Bruce, Sorin Buga, Marcin Chwistek, Charles S. Cleeland, David S. Craig, Ellin Gafford, Heather Greenlee, Eric Hansen, Arif H. Kamal, Mihir Kamdar, Susan B. LeGrand, Sean Mackey, Marc McDowell, Natalie Moryl, Lisle M. Nabell, Suzanne Nesbit, Nina O’Connor, Michael W. Rabow, Elizabeth Rickerson, Rebecca Shatsky, Jill E. Sindt, Susan G. Urba, Jeanie Youngwerth, Lydia J. Hammond, Lisa A. Gurski
Published 2019Artigo -
11
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022 by Jimmy J. Caudell, Maura L. Gillison, Ellie Maghami, Sharon Spencer, David G. Pfister, Douglas R. Adkins, Andrew C. Birkeland, David M. Brizel, Paul M. Busse, Anthony J. Cmelak, A. Dimitrios Colevas, David W. Eisele, Thomas J. Galloway, J.L. Geiger, Robert I. Haddad, Wesley L. Hicks, Ying J. Hitchcock, Antonio Jimeno, Debra S. Leizman, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, James W. Rocco, Cristina P. Rodriguez, P. Savvides, David A. Schwartz, Jatin P. Shah, David J. Sher, Maie A. St. John, Randal S. Weber, Gregory S. Weinstein, Frank Worden, Justine Y. Bruce, Sue S. Yom, Weining Zhen, Jennifer L. Burns, Susan Darlow
Published 2022Artigo
Search Tools:
Related Subjects
Cancer
Internal medicine
Medicine
Oncology
Cancer research
Head and neck cancer
Biochemistry
Clinical endpoint
Clinical trial
Head and neck squamous-cell carcinoma
Immunotherapy
Phases of clinical research
Surgery
Biology
Biomarker
Chemistry
Chemotherapy
Colorectal cancer
Gastroenterology
Immune system
Immunology
Pharmacology
Prostate cancer
Urology
Alkaline phosphatase
Alternative medicine
Androgen deprivation therapy
Anesthesiology
Bevacizumab
Breakthrough Pain